Literature DB >> 29320768

Attention Deficit Hyperactivity Disorder Symptoms are Common in Patients in Opioid Maintenance Treatment.

Kristine Fiksdal Abel1, Edle Ravndal1, Thomas Clausen1, Jørgen G Bramness2.   

Abstract

INTRODUCTION AND AIMS: Knowledge of attention deficit hyperactivity disorder (ADHD) symptoms among patients in opioid maintenance treatment (OMT) is important for treatment optimization and yet limited. We investigated the prevalence of ADHD symptoms, and factors associated with high ADHD symptom burden in a group of Norwegian OMT patients.
METHODS: We interviewed individuals entering OMT across Norway in 2 steps between 2012 and 2016. ADHD symptoms were measured by the Adult ADHD Self-Report Scale (ASRS; n = 175). We compared 2 groups of individuals who scored above or below the clinical cutoff score. Mental distress was measured with the General Symptom Index (GSI) of the Hopkin's Symptom Check-List-25.
RESULTS: A total of 33% of the OMT patients screened positively for ADHD on the ASRS. Participants who scored above the clinical cutoff were younger, and reported more severe substance use and mental distress. When controlling for other significant variables in a logistic regression analysis, scoring above cutoff on the ASRS was associated with higher GSI (OR 1.61; 95% CI 1.03-2.50) and use of stimulants (OR 2.55; 1.13-5.76).
CONCLUSIONS: ADHD symptoms were common in these OMT patients. High ADHD symptom burden was associated with higher mental distress and use of stimulants. This underlines a need of more systematic focus on ADHD in OMT to plan treatment accordingly.
© 2018 S. Karger AG, Basel.

Entities:  

Keywords:  Attention deficit hyperactivity disorder; Mental health problems; Opioid dependence; Opioid maintenance treatment

Mesh:

Substances:

Year:  2018        PMID: 29320768     DOI: 10.1159/000484240

Source DB:  PubMed          Journal:  Eur Addict Res        ISSN: 1022-6877            Impact factor:   3.015


  3 in total

1.  Substance use and symptoms of mental health disorders: a prospective cohort of patients with severe substance use disorders in Norway.

Authors:  Christer Frode Aas; Jørn Henrik Vold; Rolf Gjestad; Svetlana Skurtveit; Aaron Guanliang Lim; Kristian Varden Gjerde; Else-Marie Løberg; Kjell Arne Johansson; Lars Thore Fadnes
Journal:  Subst Abuse Treat Prev Policy       Date:  2021-02-27

2.  Adult attention-deficit hyperactivity disorders and its correlates in patients with opioid dependence: An exploratory study.

Authors:  Snehil Gupta; Gayatri Bhatia; Siddharth Sarkar; Biswadip Chatterjee; Yatan Pal Singh Balhara; Anju Dhawan
Journal:  Indian J Psychiatry       Date:  2020-10-10       Impact factor: 1.759

3.  Cognitive profiles in persons with opioid use disorder enrolled in methadone treatment.

Authors:  Victoria Sanborn; John Gunstad; Roman Shrestha; Colleen B Mistler; Michael M Copenhaver
Journal:  Appl Neuropsychol Adult       Date:  2020-05-28       Impact factor: 2.050

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.